The retail portion of Mukka Proteins’ IPO
Subscription status for Mukka Proteins‘ IPO initial public offering (IPO): Mukka Proteins produces and markets fish products for pet food, poultry feed, and aqua feed. ₹26–28 per share is the IPO pricing range. Within two hours of launching, the retail section was fully subscribed.
Subscription for Mukka Proteins’ initial public offering (IPO) begins today, Thursday, February 29, and ends on Monday, March 4.
Mukka Proteins IPO subscription status: The IPO got off to a strong start on its first day of opening, with its retail part being fully subscribed within the first two hours of opening. According to BSE data, the IPO subscription status for Mukka Proteins was 2.47 times on day 1.
The Mukka Proteins initial public offering (IPO) has seen 3.70 subscriptions from individual investors, 1.55 bookings from non-institutional investors (NII), and 1.01 bookings from qualified institutional buyers (QIB) on day 1.
Subscription for Mukka Proteins’ initial public offering (IPO) begins today, Thursday, February 29, and ends on Monday, March 4. During its IPO on Wednesday, February 28, Mukka Proteins raised ₹67.20 crores from anchor investors.
The Mukka Proteins Initial Public Offering (IPO) has set aside a minimum of 35% of the shares for retail investors, a maximum of 50% of the shares for qualified institutional buyers (QIB), and a minimum of 15% for non-institutional institutional investors (NII).
Fish meal, fish oil, and fish soluble paste are produced and sold by Mukka Proteins Ltd. These products are essential to the creation of aqua feed (for fish and prawns), chicken feed (for grilling and layering), and pet food (chow for dogs and cats). The IPO of Mukka Proteins is scheduled to take place in the region of ₹26 to ₹28 per equity share, with a face value of Re 1. The 535 equity shares that make up each IPO lot for Mukka Proteins are followed by multiples of 535 equity shares.
Mukka Proteins IPO subscription status
According to BSE data, bids have been received for 13,84,79,400 shares of the 5,60,00,435 shares that were offered in the Mukka Proteins IPO.
In the Mukka Proteins initial public offering (IPO), bids were received for 10,36,55,715 shares, out of the 2,80,00,000 shares that were offered to retail investors.
Bids were received for 1,86,14,255 shares of the Mukka Proteins IPO by non-institutional investors, out of the 1,20,00,000 shares that were offered for this segment.
Out of the 1,60,00,435 shares that were offered for this segment, 1,62,09,430 shares were received by the QIBs section of the Mukka Proteins IPO.
Mukka Proteins IPO details
The ₹224 crore Mukka Proteins IPO consists of a new issuance of 8,00,00,000 equity shares with a face value of Re 1. There is no offer-for-sale component, and this is an entirely new issue.
According to what is stated in the red herring prospectus (RHP), the company plans to use the net proceeds from the issue to finance the following: general corporate purposes, working capital requirements, and an investment in their associate, Ento Proteins Private Limited.
Fedex Securities Pvt Ltd is the book running lead manager for the Mukka Proteins IPO, while Cameo Corporate Services Limited is the registrar.
Mukka Proteins IPO GMP price today
The grey market premium, or IPO GMP, for Mukka Proteins is +15. This indicates that the share price of Mukka Proteins was trading at a premium of ₹15 on the illicit market, per investorgain.com.
Mukka Proteins’ expected listing price was ₹43 per share, 53.57% more than the IPO price of ₹28, taking into account the upper end of the IPO pricing band and the current premium in the grey market.
At 1355 GMT, April Brent crude futures were down 2 cents to $83.66 per barrel. The more active May contract was up two cents to $82.17, while the April contract expires on Thursday. Crude futures for US West Texas Intermediate rose 25 cents to $78.79.